Pharma

How Is Evonik Restructuring to Thrive in the Pharmaceutical Sector?
Manufacturing How Is Evonik Restructuring to Thrive in the Pharmaceutical Sector?

Recent developments at Evonik indicate a comprehensive restructuring strategy aimed at enhancing its position within the pharmaceutical sector. The company's ongoing initiative, tagged “Evonik Tailor Made,” is set to streamline operations and realign its focus on high-value pharmaceutical pro

Nipro Launches D2F Glass Vials with EZ-fill Tech for Aseptic Efficiency
Manufacturing Nipro Launches D2F Glass Vials with EZ-fill Tech for Aseptic Efficiency

Nipro PharmaPackaging has introduced its revolutionary D2F (Direct-to-Fill) glass vials, incorporating the cutting-edge EZ-fill technology from Stevanato Group. These innovative vials are specifically designed to meet the stringent demands of the pharmaceutical industry's evolving need for

Synexa Acquires Alderley Analytical to Enhance Drug Development Services
Manufacturing Synexa Acquires Alderley Analytical to Enhance Drug Development Services

In a significant advancement of its strategic growth initiatives, Synexa Life Sciences has acquired Alderley Analytical Ltd. This acquisition is a crucial element in Synexa's ongoing 'buy and build' strategy, aimed at expanding and enhancing its capabilities in the biomarker and

Why Is the Alliance for RTU Transforming Pharmaceutical Manufacturing?
Manufacturing Why Is the Alliance for RTU Transforming Pharmaceutical Manufacturing?

A new strategic alliance has been formed among three industry leaders in pharmaceutical packaging—Gerresheimer, Stevanato Group, and SCHOTT Pharma. Collectively known as the "Alliance for RTU," the partnership aims to promote the adoption of Ready-to-Use (RTU) vials and cartridges in the p

CPHI Milan's 35th Year: Celebrating Pharma Innovations and Future Growth
Manufacturing CPHI Milan's 35th Year: Celebrating Pharma Innovations and Future Growth

This year, CPHI Milan marks its 35th anniversary, a testament to its pivotal role in shaping the global pharmaceutical supply chain. With an expected attendance of 62,000 professionals from over 100 countries, the event underscores the industry's collaborative spirit and relentless pursuit of

How Is Quotient Sciences Revolutionizing Personalized Medicine?
Manufacturing How Is Quotient Sciences Revolutionizing Personalized Medicine?

In a rapidly evolving biopharmaceutical landscape, Quotient Sciences stands out for its relentless drive toward innovation in personalized medicine. Spearheaded by CEO Thierry Van Nieuwenhove, the company has made significant strides, particularly in the areas of pediatric therapies and emerging

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later